Skip to content
Investment Visual

BMY

Bristol-Myers Squibb Company

$63.43+1.11 (+1.78%)Close Nov 13, 2026

Backtest BMY

Insider trading

12 months to Nov 6, 2026
Sold
$2.53M
4 insiders
Largest seller
$1.85M
David V. Elkins · 73% of sales
Plan sales
$1.85M
73% of sales
Latest buy
Apr 25, 2025
Samit Hirawat

Buys and sales on the price

Since 2003

By period

Open-market trades
Trades3 months12 monthsSince 2003
Buys0021
Sales34336
Plan sales01147
Shares bought0000226,176226K
Shares sold10,54910.5K40,54940.5K9,832,4019.83M
Net shares−10,549−10.5K−40,549−40.5K−9,606,224−9.61M
Net value−$678K−$2.53M−$486M

Insiders

Insider12 monthsShares held
Christopher S. Boerner
Chief Executive Officer, Director
—
273,975
David V. Elkins
EVP, Chief Financial Officer
−17.9%
159,542
as of Apr 2, 2026
Gregory Scott Meyers
EVP, Chief Digital & Tech Off.
—
33,977
Adam Lenkowsky
EVP, Chief Commercial Officer
—
32,437
Karin Shanahan
EVP, Chief Supply Chain & Ops
—
30,414

Trades

357 trades since 2003
TypeInsiderRoleSharesPriceHeld after
Nov 5, 2026Sale
Julia A. HallerDirector
Director
Director
3,800
at $63.31
$63.31$241K
−11.2%
30.3K after
30,279
Sep 9, 2026Sale
Cristian MassacesiEVP,Chief Med Offr,Head of Dev
EVP,Chief Med Offr,Head of Dev
EVP,Chief Med Offr,Head of Dev
6,249
at $64.57
$64.57$403K
−25.0%
18.7K after
18,748
Aug 25, 2026Sale
Phil M. HolzerSVP and Controller
SVP and Controller
SVP and Controller
500
at $67.50
$67.50$33.8K
−2.9%
16.9K after
16,862
Apr 1, 2026Plan sale
David V. ElkinsEVP, Chief Financial Officer
EVP, Chief Financial Officer
EVP, Chief Financial Officer
30,000
at $61.67
$61.67$1.85M
−15.8%
Changed by trades not shown: 160K after
Changed by trades not shown: 159,542
Sep 2, 2025Plan sale
David V. ElkinsEVP, Chief Financial Officer
EVP, Chief Financial Officer
EVP, Chief Financial Officer
56,000
at $47.33
$47.33$2.65M
−25.0%
168K after
167,662
Aug 2, 2025Sale
Bartie Wendy ShortEVP, Corporate Affairs
EVP, Corporate Affairs
EVP, Corporate Affairs
378
at $44.23
$44.23$16.7K
−6.9%
5.07K after
5,066
May 9, 2025Sale
Benjamin HickeyPresident, RayzeBio Org.
President, RayzeBio Org.
President, RayzeBio Org.
97
at $38.01
$38.01$3.70K
−1.1%
8.79K after
8,789
Apr 25, 2025Buy
Samit HirawatEVP,Chief Med.Offr.,Drug Dev.
EVP,Chief Med.Offr.,Drug Dev.
EVP,Chief Med.Offr.,Drug Dev.
4,250
at $47.58
$47.58$202K
+5.4%
Changed by trades not shown: 83.5K after
Changed by trades not shown: 83,513
Feb 20, 2025Buy
Christopher S. BoernerChief Executive Officer, Director
Chief Executive Officer, Director
Chief Executive Officer, Director
2,000
at $55.05
$55.05$110K
+1.9%
105K after
104,626
Feb 14, 2025Buy
Samit HirawatEVP,Chief Med.Offr.,Drug Dev.
EVP,Chief Med.Offr.,Drug Dev.
EVP,Chief Med.Offr.,Drug Dev.
1,823
at $54.84
$54.84$100K
+2.9%
63.9K after
63,932
  • Julia A. Haller$241K
    Nov 5, 2026 · Sale3,800 at $63.31
    Director−11.2% of holdings, 30.3K after
  • Cristian Massacesi$403K
    Sep 9, 2026 · Sale6,249 at $64.57
    EVP,Chief Med Offr,Head of Dev−25.0% of holdings, 18.7K after
  • Phil M. Holzer$33.8K
    Aug 25, 2026 · Sale500 at $67.50
    SVP and Controller−2.9% of holdings, 16.9K after
  • David V. Elkins$1.85M
    Apr 1, 2026 · Plan sale30,000 at $61.67
    EVP, Chief Financial Officer−15.8% of holdings, Changed by trades not shown: 160K after
  • David V. Elkins$2.65M
    Sep 2, 2025 · Plan sale56,000 at $47.33
    EVP, Chief Financial Officer−25.0% of holdings, 168K after
  • Bartie Wendy Short$16.7K
    Aug 2, 2025 · Sale378 at $44.23
    EVP, Corporate Affairs−6.9% of holdings, 5.07K after
  • Benjamin Hickey$3.70K
    May 9, 2025 · Sale97 at $38.01
    President, RayzeBio Org.−1.1% of holdings, 8.79K after
  • Samit Hirawat$202K
    Apr 25, 2025 · Buy4,250 at $47.58
    EVP,Chief Med.Offr.,Drug Dev.+5.4% of holdings, Changed by trades not shown: 83.5K after
  • Christopher S. Boerner$110K
    Feb 20, 2025 · Buy2,000 at $55.05
    Chief Executive Officer, Director+1.9% of holdings, 105K after
  • Samit Hirawat$100K
    Feb 14, 2025 · Buy1,823 at $54.84
    EVP,Chief Med.Offr.,Drug Dev.+2.9% of holdings, 63.9K after